文献速递生殖医学

体外受精后妊娠部位不明管理单次就诊方案的制定:一项回顾性研究

Development of a single-visit protocol for the management of pregnancy of unknown location following in vitro fertilization: a retrospective study.
PubMed 文献 · Hum Reprod · 2024-01-01

本研究回顾了2008年5月至2021年1月两家早期妊娠评估单位中体外受精(IVF)后妊娠部位不明(PUL)且孕周≥5周的210例女性,发现血清hCG与受孕天数比值(hCG/C)或初始血清hCG水平可用于风险分层,hCG/C<4.0与1.9%的干预风险相关,占研究人群25.7%。

要点

  • IVF后PUL女性中,30/210(14.0%,95%CI 9.9-19.8)需要手术干预。
  • 需干预组hCG/C显著高于无需干预组(P=0.003),OR为3.65(95%CI 1.49-8.89,P=0.004)。
  • hCG/C<4.0与1.9%干预风险相关,占研究人群25.7%;初始hCG<100 IU/l与2.0%风险相关,占23.8%。

核心结论

  • IVF后PUL女性可根据初始就诊时的人口学特征和血清生化结果进行风险分层,以评估后续是否需要医疗干预。
  • hCG/C或孕周≥5周时的初始血清hCG水平可用于估计需要医疗干预的风险。

研究设计与样本

  • 回顾性研究,2008年5月至2021年1月在两家专科早期妊娠评估单位开展。
  • 共224例女性符合纳入标准,14例未完成随访被排除,最终分析210例。
  • 纳入标准为IVF妊娠且孕周≥5周时表现为PUL。

主要发现

  • 30/210(14.0%,95%CI 9.9-19.8)最初诊断为PUL的女性需要手术干预。
  • 需干预组hCG/C显著高于无需干预组(P=0.003),OR为3.65(95%CI 1.49-8.89,P=0.004)。
  • hCG/C<4.0与1.9%的干预风险相关,占研究人群25.7%。
  • 初始hCG<100 IU/l与2.0%的干预风险相关,占研究人群23.8%(P>0.05)。

关键数值与推荐

  • hCG/C<4.0:干预风险1.9%,占研究人群25.7%。
  • 初始hCG<100 IU/l:干预风险2.0%,占研究人群23.8%(P>0.05)。
  • 以2%为 cutoff,四分之一IVF后PUL女性可避免进一步就诊和检查。

临床怎么用

  • 作者认为,使用2%的干预风险 cutoff,四分之一IVF后PUL女性可避免后续就诊和检查。

局限性

  • 研究为回顾性性质,因此依赖于现有数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can women with pregnancy of unknown location (PUL) following in vitro fertilization (IVF) be risk-stratified regarding the subsequent need for medical intervention, based on their demographic characteristics and the results of serum biochemistry at the initial visit? SUMMARY ANSWER: The ratio of serum hCG to number of days from conception (hCG/C) or the initial serum hCG level at ≥5 weeks' gestation could be used to estimate the risk of women presenting with PUL following IVF and needing medical intervention during their follow-up. WHAT IS KNOWN ALREADY: In women with uncertain conception dates presenting with PUL, a single serum hCG measurement cannot be used to predict the final pregnancy outcomes, thus, serial levels are mandatory to establish a correct diagnosis. Serum progesterone levels can help to risk-stratify women at their initial visit but are not accurate in those taking progesterone supplementation, such as women pregnant following IVF. STUDY DESIGN, SIZE, DURATION: This was a retrospective study carried out at two specialist early pregnancy assessment units between May 2008 and January 2021. A total of 224 women met the criteria for inclusion, but 14 women did not complete the follow-up and were excluded from the study. PARTICIPANTS/MATERIALS, SETTING, METHODS: We selected women who had an IVF pregnancy and presented with PUL at ≥5 weeks' gestation. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 30/210 (14.0%, 95% CI 9.9-19.8) women initially diagnosed with PUL required surgical intervention. The hCG/C was significantly higher in the group of women requiring an intervention compared to those who did not (P = 0.003), with an odds ratio of 3.65 (95% CI 1.49-8.89, P = 0.004). A hCG/C <4.0 was associated with a 1.9% risk of intervention, which accounted for 25.7% of the study population. A similar result was obtained by substituting hCG/C <4.0 with an initial hCG level <100 IU/l, which was associated with 2.0% risk of intervention, and accounted for 23.8% of the study population (P > 0.05). LIMITATIONS, REASONS FOR CAUTION: A limitation of our study is that it is retrospective in nature, and as such, we were reliant on existing data. WIDER IMPLICATIONS OF THE FINDINGS: A previous study in women with PUL after spontaneous conception found that a 2% intervention rate was considered low enough to eliminate the need for close follow-up and serial blood tests. Using the same 2% cut-off, a quarter of women with PUL after IVF could also avoid attending for further visits and investigations. STUDY FUNDING/COMPETING INTEREST(S): No external funding was required for this study. No conflicts of interest are required to be declared. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Dooley WM, de Braud LV, Wong M, et al. Development of a single-visit protocol for the management of pregnancy of unknown location following in vitro fertilization: a retrospective study. Hum Reprod. 2024. PMID: 38265302. doi:10.1093/humrep/deae002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。